Workflow
ZHONG JI LS(00767)
icon
Search documents
中基长寿科学(00767) - 2020 - 年度财报
2021-04-29 08:37
Financial Performance - Revenue for 2020 was HK$80,022,000, a decrease of 45% compared to HK$145,846,000 in 2019[14]. - The profit attributable to the owners of the company for 2020 was a loss of HK$11,487,000, compared to a loss of HK$825,678,000 in 2019[14]. - For the year ended December 31, 2020, the Group's revenue was approximately HK$80,022,000, with a loss of approximately HK$10,700,000[20]. - The loss for the year narrowed to approximately HK$10,700,000, significantly reduced from HK$825,969,000 in 2019, with basic and diluted loss per share at approximately HK0.30 cents[38]. - The money lending business generated segmental revenue of approximately HK$61,154,000, a decline from HK$121,973,000 in 2019, due to increased corporate debt defaults amid the pandemic[45]. - Interest income from the money lending business was approximately HK$48,081,000, a decrease from HK$85,292,000 in 2019, highlighting the impact of the challenging economic environment[45]. - The loan facilitation services business recorded no revenue for the year, down from HK$16,000 in 2019, indicating significant operational challenges[40]. - The Group incurred a net fair value loss of approximately HK$510,750,000 on listed securities investments, compared to a net fair value gain of HK$234,767,000 in 2019[49]. - The fair value of the Group's investment in Imperial Pacific shares was approximately HK$54,269,000, down from HK$558,971,000 in 2019, with a net fair value loss of approximately HK$504,702,000 recognized[55]. - The Group recorded net current assets of approximately HK$156,120,000, down from HK$299,308,000 in 2019, and cash and cash equivalents of approximately HK$40,797,000, down from HK$154,958,000 in 2019[84]. - The gearing ratio of the Group as of December 31, 2020, was approximately 1.6%, an increase from 0.7% in 2019[90]. Assets and Investments - Total assets as of December 31, 2020, amounted to HK$454,886,000, down from HK$967,369,000 in 2019, representing a decrease of approximately 53%[16]. - The company reported a significant reduction in equity investments designated at fair value through other comprehensive income, dropping to HK$73,345,000 from HK$603,385,000 in 2019[16]. - As of December 31, 2020, the consolidated net assets of the Group were approximately HK$454,886,000, down from HK$967,369,000 in 2019[39]. - The Group held an investment in 72,500,000 shares of Capital Environment, with a cost of approximately HK$25,793,000, and a fair value of HK$8,700,000 as of December 31, 2020[57]. - The Group's investment in Chuangxin Environment Holdings had a fair value of HK$8,700,000, representing 11.9% of total listed securities investments and 1.8% of total assets[60]. Strategic Focus and Growth Plans - The company plans to focus on expanding its market presence and developing new technologies in the longevity science sector[17]. - The management indicated potential for future growth through strategic partnerships and acquisitions in related industries[17]. - The company aims to leverage its existing assets and capabilities to explore new business opportunities in the health and wellness market[17]. - The Group aims to expand its longevity science business, targeting a market potential of RMB 304 billion for NMN products, with long-term growth prospects reaching a scale of over RMB 1 trillion[30]. - The Group plans to enhance its investment in longevity biological products, cell and gene therapy, and advanced medical technologies to capture market opportunities[30]. - The Group's vision is to help people live longer and healthier lives through innovative life management solutions across various sectors[34]. - The Group aims to establish a full value chain for NMN longevity biological products by leveraging its technology in longevity science, cell and gene therapies, and advanced medical technologies[28]. - The Group is committed to launching more products through various channels globally to expand its market share in longevity biological products[28]. - The Group plans to conduct mergers and acquisitions of advanced medical treatment and testing projects to refine its global layout in longevity science[24]. - The Group entered into an agreement to acquire two medical testing centers providing a total of 19 types of health index and disease detection tests[24]. Research and Development - The Group has invested in longevity science research and recruited an elite team, including Nobel laureate Randy Wayne Schekman as Honorary Chairman and Chief Scientist[24]. - The Group focused on the R&D and production of its flagship Nicotinamide Mononucleotide (NMN) product "ZJ1," with a production plant leased in California covering 36,000 square feet[71]. - The R&D team advanced the development of "ZJ1" to the fifth generation, aiming to maintain cellular dynamic equilibrium for health and longevity[71]. - The Group appointed Nobel Prize winners and biotechnology experts to strengthen its R&D capabilities in the longevity science sector[70]. - The management team is pushing forward R&D efforts, with the fifth-generation NMN seaweed capsules launched in 2021, aiming to establish a full industry chain for NMN products[79]. Corporate Governance and Structure - The Group's name change to Zhong Ji Longevity Science Group Limited marks a significant milestone in its business transformation journey[27]. - The company emphasizes the importance of independent directors in maintaining transparency and accountability in its operations[117][120]. - The governance structure is designed to ensure effective oversight and strategic direction, aligning with best practices in corporate governance[121]. - The company has a strong board composition with members possessing diverse backgrounds in law, finance, and corporate management, which supports strategic decision-making[121][124]. - The company appointed several independent non-executive directors, enhancing its governance structure[117][118][120]. - The leadership team is committed to leveraging their diverse expertise to drive growth and enhance shareholder value[109][111][115][116]. Market Trends and Economic Outlook - The global anti-aging market reached US$190 billion in 2019, growing by 8.3% year-on-year, with a similar trend observed in Mainland China[66]. - The International Monetary Fund (IMF) projects global economic growth of 5.5% in 2021, with China's GDP growth estimated at 8.1%, indicating a robust recovery and increased demand for health and longevity services[78]. Compliance and ESG Initiatives - The company has complied with relevant laws and regulations, including the Money Lenders Ordinance and the Hong Kong Companies Ordinance, for the year ended December 31, 2020[141]. - An ESG report will be published on the company's website by the end of May 2021, detailing its compliance with ESG policies[140]. - The company aims to enhance long-term performance through improvements in environmental, social, and governance matters[140]. - The company is committed to building an environmentally friendly working environment by promoting energy savings and recycling[140].
中基长寿科学(00767) - 2020 - 中期财报
2020-09-10 08:29
Financial Performance - For the six months ended June 30, 2020, the company recorded segment revenue of approximately HK$10,386,000, a decrease of 74.3% from HK$40,413,000 in the same period of 2019[55] - The segment profit for the same period was approximately HK$19,102,000, down 52.0% from HK$39,694,000 in the prior year[55] - For the six months ended June 30, 2020, the Group reported a net fair value loss of approximately HK$371,510,000 from listed securities investments, compared to a net fair value gain of HK$844,412,000 for the same period in 2019[70] - The Group recorded a profit of approximately HK$16,039,000 for the six months ended June 30, 2020, down 58.2% from HK$38,362,000 in the previous year[115] - Basic and diluted earnings per share were HK0.41 cents and HK0.11 cents respectively, compared to HK0.98 cents and HK0.26 cents for the same period in 2019[115] - For the six months ended June 30, 2020, the Group's revenue was approximately HK$20,956,000, a decrease of 71.9% compared to HK$74,551,000 for the same period in 2019[115] Loan and Interest Income - Interest income recorded by Joy Wealth for the six months ended June 30, 2020, was approximately HK$536,000, a significant decrease from HK$39,300,000 in the same period of 2019[45] - The Group recorded interest income of approximately HK$4,029,000 from trust beneficiary rights for the six months ended June 30, 2020, down from HK$9,087,000 for the same period in 2019[85] - The Group has prudently made a provision for impairment of approximately HK$120,000 for receivables due to the financial status of borrowers[60] - The company made impairment provisions for loan and interest receivables of approximately HK$120,000 for the six months ended June 30, 2020, while there were no provisions in the same period of 2019[55] Business Operations - The company ceased the business of loan facilitation services to allocate more resources to its principal businesses[44] - The Group continues to actively negotiate with borrowers to recover outstanding loans and interest receivables[59] - The Group has initiated legal proceedings against borrowers for outstanding loans and interest, with a hearing scheduled for September 14, 2020[61] Investments - The Group's investment in shares of Imperial Pacific amounted to approximately HK$76,490,000, representing about 3.8% of Imperial Pacific's issued share capital as of June 30, 2020[71] - The fair value of the shares of Imperial Pacific held by the Group was approximately HK$200,795,000 as of June 30, 2020, down from HK$558,971,000 as of December 31, 2019, representing 86.6% of the Group's total investment in listed securities[80] - The net fair value loss for the investment in shares of Imperial Pacific during the six months ended June 30, 2020, was approximately HK$358,176,000, compared to a net fair value gain of HK$841,169,000 for the same period in 2019[80] Current Assets and Liabilities - As of June 30, 2020, the Group had net current assets of approximately HK$330,893,000, an increase from HK$299,308,000 as of December 31, 2019[120] - Cash and bank balances were approximately HK$80,885,000, down from HK$154,958,000 as of December 31, 2019[120] - The gearing ratio as of June 30, 2020, was approximately 1.1%, up from 0.7% as of December 31, 2019[130] - The Group's debt-to-equity ratio was approximately 1.1%, an increase from 0.7% as of December 31, 2019[136] Future Outlook - The second half of the year is expected to remain challenging due to the ongoing impact of COVID-19 on the global economy[98] - The Group plans to continue expanding its business varieties to broaden income sources and seek potential investment opportunities[99] Shareholder Information - As of June 30, 2020, the total number of shares issued by the company was 3,870,102,650[195] - Ng Kwok Fai holds a long position of 2,129,143,068 shares, representing approximately 336.97% of the issued share capital[188] - Harmony Delight Holdings Limited is deemed to be interested in 10,912,000,000 shares, which is approximately 281.96% of the issued share capital[188] - Grand Harbour Finance Limited holds a long position of 2,129,143,068 shares, accounting for 55.02% of the issued share capital[188] - Success Seven Limited has a long position of 192,324,703 shares, representing 4.97% of the issued share capital[191] - Jiang Jianhui holds a long position of 2,321,467,771 shares, which is approximately 59.98% of the issued share capital[191] - Allied Summit Inc. has a long position of 580,659,755 shares, accounting for 15.00% of the issued share capital[191] - DeTai Finance Limited holds a long position of 580,659,755 shares, representing 15.00% of the issued share capital[191] - The company has not been notified of any other interests or short positions in the shares and underlying shares as of June 30, 2020[195] - Harmony Delight Holdings Limited holds convertible notes with a principal amount of HK$2,182,400,000, convertible into a maximum of 10,912,000,000 shares[195] Miscellaneous - The company did not declare an interim dividend for the six months ended June 30, 2020, consistent with the previous year[42] - The accumulated amount of loans provided by Joy Wealth Finance Limited since 2011 is approximately HK$2,536 million, unchanged from June 30, 2019[45] - The interest rates for loans during the six months ended June 30, 2020, ranged from 10% to 15%, compared to 9% to 15% in the previous year[45] - The Group had no capital commitments as of June 30, 2020, consistent with the previous year[165] - There were no material contingent liabilities reported as of June 30, 2020[167] - The Group has not implemented any foreign currency hedging policy but continuously monitors foreign exchange exposure due to fluctuations in the Renminbi[162] - The Group's corporate mission includes exploring ways to improve financial performance and diversifying into more profitable businesses[149] - The Group may consider debt and/or equity fundraising plans to meet financing needs arising from business development[151] - There have been no major subsequent events from June 30, 2020, to the date of the report[170] - As of June 30, 2020, none of the Directors or the chief executive had any interests or short positions in the shares of the Company[180] - As of June 30, 2020, the fair value of trust investments was approximately HK$35,095,000, a decrease from HK$59,755,000 as of December 31, 2019[88] - The fair value of trust investments was approximately HK$35,095,000 as of June 30, 2020, down from HK$59,755,000 as of December 31, 2019[88]
中基长寿科学(00767) - 2019 - 年度财报
2020-05-14 09:09
Financial Performance - For the year ended December 31, 2019, the Group's revenue was approximately HK$145,846,000, a decrease of 19.0% from HK$180,048,000 in 2018[15]. - The Group recorded a loss of approximately HK$825,969,000 for 2019, significantly improved from a loss of HK$2,196,597,000 in 2018[15]. - Basic and diluted losses per share were HK21.33 cents in 2019, compared to HK56.82 cents in 2018[15]. - The loan facilitation services segment recorded revenue of approximately HK$16,000, a significant decrease from HK$63,154,000 in 2018, and a profit of approximately HK$15,000 compared to a loss of HK$2,130,679,000 in 2018[23]. - The money lending business generated interest income of approximately HK$85,292,000 for the year, down from HK$88,212,000 in 2018, with an accumulated loan amount of approximately HK$2,536 million[26]. - The money lending segment reported revenue of approximately HK$121,973,000, an increase from HK$96,378,000 in 2018, but incurred a loss of approximately HK$815,636,000 due to an impairment of loan and interest receivables of approximately HK$920,774,000[28]. - The Group recognized a net fair value gain of approximately HK$234,767,000 from investments in listed securities, a recovery from a net fair value loss of HK$387,569,000 in 2018[30]. - The Group's consolidated net asset value was approximately HK$967,369,000, down from HK$1,566,771,000 in 2018[21]. - For the year ended December 31, 2019, the Group recorded interest income of approximately HK$14,844,000 from the Trust investment, down from HK$19,949,000 in 2018[40]. Assets and Liabilities - As of December 31, 2019, the consolidated net assets of the Group were approximately HK$967,369,000, down from HK$1,566,771,000 in 2018, representing a decrease of 38.3%[16]. - The total equity attributable to shareholders decreased to HK$967,369,000 in 2019 from HK$1,566,771,000 in 2018, reflecting a decline of 38.3%[12]. - The Group's plant and equipment value decreased to HK$339,000 in 2019 from HK$1,019,000 in 2018, indicating a reduction of 66.8%[12]. - The Group's financial assets at amortized cost decreased to HK$59,755,000 in 2019 from HK$157,295,000 in 2018, a decline of 62.0%[12]. - As of December 31, 2019, the Group's net current assets were approximately HK$299,308,000, a decrease from HK$1,038,703,000 in 2018, and cash and bank balances were approximately HK$154,958,000, down from HK$179,705,000[48][52]. - As of December 31, 2019, the Group had a gearing ratio of approximately 0.7%, with a net cash position as of December 31, 2018, and no borrowings[70]. - The fair value of the Trust investment decreased to approximately HK$59,755,000 as of December 31, 2019, compared to HK$157,295,000 in 2018[40][43]. Business Activities and Strategy - The Group's principal business activities include loan facilitation services, money lending, securities and other investments, and financial and investment advisory[17]. - The Group is focused on expanding its investment portfolio and enhancing its financial advisory services in the coming years[17]. - The Group aims to diversify its investment portfolio and seek stable and sustainable development opportunities to enhance shareholder value[41][47]. - The Group plans to utilize idle resources to purchase principal-guaranteed wealth management products with expected higher returns compared to savings deposits in the PRC[42][44]. - The Company is exploring ways to improve financial performance and diversify operations into more profitable businesses[67]. - The Company may consider debt and/or equity fundraising plans to meet financing needs arising from business development[67]. Corporate Governance and Compliance - The Group will continue to strengthen corporate governance and risk prevention mechanisms to achieve steady growth and development[47][51]. - The Group has complied with relevant laws and regulations, including the Money Lenders Ordinance and the Hong Kong Companies Ordinance, for the year ended December 31, 2019[114][117]. - The Company has adopted a treasury policy to control and govern possible future securities investments[69]. - The Company has maintained a register of interests and short positions as required by the Securities and Futures Ordinance[189]. Shareholder Information - The total number of issued shares of the Company remained unchanged at 3,870,102,650 shares as of December 31, 2019[49][53]. - The Company did not recommend the payment of any dividend for the year ended December 31, 2019[87]. - The substantial shareholder Hong Kong Financial Services Asset Management L.P. held 2,129,143,068 shares in long position, representing approximately 336.97% of the issued share capital of the Company[190]. - The Company has not entered into any arrangements enabling Directors to acquire benefits through shares or debentures during the year ended December 31, 2019[174]. Employee and Management Information - The Group employed 42 employees as of December 31, 2019, primarily located in Hong Kong and China[64]. - The Group provides in-house training programs to enhance employee skills and knowledge, along with performance reviews and bonuses[106]. - The Company has a share option scheme as incentives for employees, in addition to retirement benefits and medical insurance[106]. - Mr. Yeung Siu Keung joined the Group as a project manager on December 16, 2019, and was appointed as an executive director on December 17, 2019[92]. - The Directors who held office during the year include Mr. Yeung Siu Keung and Mr. Lee Man To, both of whom will offer themselves for re-election at the upcoming annual general meeting[171]. Other Relevant Information - The Group completed the acquisition of Sky State Holdings Limited on February 1, 2019, for a cash consideration of HK$25,000,000, which resulted in a segment revenue of approximately HK$8,941,000 and a segment loss of approximately HK$1,969,000 for the year[39][54]. - The Company has not purchased or redeemed any of its listed securities during the year, with 3,870,102,650 ordinary shares issued as of December 31, 2019[147]. - The aggregate revenue from the company's five largest customers accounted for approximately 73% of total revenue, with the largest customer representing 23%[197]. - The company had no management contracts other than employment contracts during the year[196].
中基长寿科学(00767) - 2019 - 中期财报
2019-09-20 08:46
Financial Performance - The Group recorded segment revenue of approximately HK$19,000 for the six months ended June 30, 2019, a significant decrease from HK$62,986,000 for the same period in 2018, reflecting a decline in loan facilitation services [31]. - The segment loss for the same period was approximately HK$1,488,000, compared to a segment loss of HK$1,663,553,000 in the previous year, indicating an improvement despite the revenue drop [31]. - The decrease in revenue was primarily attributed to reduced demand for loan facilitation services due to a slowdown in China's economy and tightening regulatory measures [31]. - The overall market conditions have pressured the Group's financial performance, necessitating a reevaluation of its service offerings and strategies moving forward [31]. Dividend and Shareholder Returns - The Board has resolved not to declare an interim dividend for the six months ended June 30, 2019, consistent with the previous year [29]. - The Group aims to diversify its investment portfolio and enhance shareholder value through stable and sustainable investments [82]. - The Company is actively seeking ways to enhance financial performance and diversify into more profitable industries while assessing existing investment portfolios [132]. Investments and Acquisitions - The acquisition of Katar Global Limited and its subsidiaries has been a key part of the Group's strategy since October 20, 2015, enhancing its service offerings in the P2P financing sector [31]. - The Group completed the acquisition of Sky State Holdings Limited on 1 February 2019, generating segment revenue of approximately HK$11.1 million and segment profits of approximately HK$2.8 million for the six months ended June 30, 2019 [84]. - The Group's investments in listed equity securities had a fair value of approximately HK$1,214.1 million as of 30 June 2019, significantly up from HK$369.7 million at the end of 2018 [45]. - The net fair value gain from these investments was approximately HK$844.4 million for the six months ended 30 June 2019, compared to a net fair value loss of HK$206.8 million in the same period of 2018 [45]. Market Conditions and Regulatory Environment - The tightening of market liquidity has led to a series of defaults, significantly impacting investment and financing activities in the market [31]. - The Group continues to monitor regulatory changes and market conditions to adapt its business strategies accordingly [31]. Financial Position and Assets - As of June 30, 2019, the Group recorded net current assets of approximately HK$1,125,709,000, an increase from HK$1,038,703,000 as of December 31, 2018 [104]. - The Group's cash and bank balances were approximately HK$104,488,000 as of June 30, 2019, down from HK$179,705,000 as of December 31, 2018 [104]. - The Group had no capital commitments as of June 30, 2019, consistent with the previous year [144]. - There were no material contingent liabilities reported as of June 30, 2019, similar to the status at the end of 2018 [145]. Corporate Governance and Risk Management - The Group plans to continue strengthening corporate governance and risk prevention mechanisms to achieve steady growth and development [100]. - The Group does not rule out the possibility of engaging in debt or equity fundraising plans to meet financing needs for business development [132]. - The Group has not implemented any foreign currency hedging policy but is continuously monitoring foreign exchange exposure due to fluctuations in Renminbi [143]. Share Capital and Options - The Group's total number of issued ordinary shares remained at 3,870,102,650 as of June 30, 2019 [110]. - The Company issued convertible notes amounting to HK$2,182,400,000, with a maximum of 10,912,000,000 shares to be issued upon full conversion [180]. - The Share Option Scheme allows for the issuance of up to 10% of the Company's shares, equating to 387,010,265 shares, as approved on 2 June 2017 [188]. - The maximum number of shares that can be issued upon exercise of share options in any 12-month period is limited to 1% of the total shares in issue unless shareholder approval is obtained [197].
中基长寿科学(00767) - 2018 - 年度财报
2019-04-26 09:56
Financial Performance - For the year ended December 31, 2018, the Group's revenue was approximately HK$180,048,000, a decrease of 34.1% from HK$273,347,000 in 2017[19] - The Group recorded a loss of approximately HK$2,196,597,000 in 2018, compared to a profit of HK$87,449,000 in 2017, resulting in basic and diluted losses per share of HK56.82 cents[19] - The total shareholders' equity as of December 31, 2018, was HK$1,566,771,000, down from HK$4,180,232,000 in 2017, reflecting a decline of 62.5%[117] - The Group experienced a net fair value loss of approximately HK$387,569,000 on listed securities for the year ended December 31, 2018, compared to a loss of HK$11,518,000 in 2017[30] - The profit attributable to the owners of the Company for 2018 was a loss of HK$2,199,094,000, compared to a profit of HK$82,274,000 in 2017[114] Segment Performance - The segment revenue from the operation of the P2P financing platform was approximately HK$63,154,000 in 2018, a decline of 61.6% from HK$164,730,000 in 2017[22] - The segment loss for the P2P financing platform was approximately HK$2,130,812,000 in 2018, compared to a segment profit of HK$151,055,000 in 2017[22] - The decrease in segment revenue and profit was primarily due to a reduction in the provision of P2P financing platform services during the year[22] - For the year ended December 31, 2018, the Group recorded segment revenue of approximately HK$63,154,000, a decrease from HK$164,730,000 in 2017, primarily due to reduced P2P financing platform services[27] Assets and Liabilities - As of December 31, 2018, the consolidated net assets of the Group were approximately HK$1,566,771,000, down from HK$4,180,232,000 in 2017[20] - As of December 31, 2018, the Group recorded net current assets of approximately HK$1,038,703,000, a decrease from HK$1,244,731,000 in 2017, and cash and bank balances of approximately HK$179,705,000[45] - The Group's current liabilities increased to HK$140,309,000 in 2018 from HK$125,176,000 in 2017[117] - The Group had cash and bank balances of approximately HK$179,705,000 as of December 31, 2018, down from HK$218,956,000 as of December 31, 2017[49] Corporate Governance - The Board is committed to high standards of corporate governance practices to enhance investor confidence and maximize shareholder returns[120] - The Company complied with the Corporate Governance Code provisions during the year, with some deviations noted[121] - The Board consists of three executive Directors, two non-executive Directors, and three independent non-executive Directors as of the report date[123] - The Company has established three board committees: Audit Committee, Remuneration Committee, and Nomination Committee, which are provided with sufficient resources to perform their duties[133] - The Company emphasizes strong corporate governance principles to ensure the Board operates independently and is well-informed on key strategic issues[131] Management and Leadership - Mr. Li Jiuhua has over 35 years of experience in the securities and finance industries, having been appointed as executive director and CEO in 2017[86][87] - Ms. Kuang Jiaying has 7 years of experience in investment and asset management, previously serving in various roles within the Group's peer-to-peer online financing platform[89] - The Group's management team includes experienced professionals with backgrounds in finance, business studies, and economics, enhancing its operational capabilities[88][90] Future Plans and Strategies - The Company aims to enhance its business operations and explore new opportunities in the financial services sector moving forward[21] - The Group plans to continue expanding its business varieties to broaden income sources and seek potential investment opportunities[44] - The Group aims to strengthen corporate governance and risk prevention mechanisms to improve overall system management and achieve steady growth[44] Shareholder Relations - The Group expresses gratitude to shareholders, customers, suppliers, and business partners for their continued support[84] - The Group did not recommend the payment of any dividend for the year ended December 31, 2018, consistent with the previous year[78] - The Group has not purchased, sold, or redeemed any of its shares during the year[83] Risk Management - The Group has not implemented any foreign currency hedging policy but continuously monitors foreign exchange exposure due to fluctuations in Renminbi[74] - The Group had no material contingent liabilities as of December 31, 2018[76] - The Group's strategic focus includes monitoring foreign exchange risks and considering hedging when significant impacts arise[80]